1. Garcinia mangostana Suppresses Triacylglycerol Synthesis in Hepatocytes and Enterocytes.
- Author
-
Kwon, Eun-Bin, Moon, Dong-Oh, Oh, Eun Sol, Song, Yu Na, Park, Ji-Yoon, Ryu, Hyung Won, Kim, Doo-Young, Chin, Young-Won, Lee, Hyun-Sun, Lee, Su Ui, and Kim, Mun-Ock
- Subjects
- *
TRIGLYCERIDES , *IN vitro studies , *LIPASES , *MEDICINAL plants , *ANIMAL experimentation , *INFLAMMATION , *ANTI-inflammatory agents , *ORGANIC compounds , *TRADITIONAL medicine , *METABOLIC disorders , *RESEARCH funding , *TRANSFERASES , *PLANT extracts , *ETHANOL , *LIVER cells , *EPITHELIAL cells , *MOLECULAR structure , *MICE , *PHARMACODYNAMICS - Abstract
Regulation of diacylglycerol acyltransferase (DGAT) and pancreatic lipase (PL) activities is important in the treatment of triacylglycerol (TG)-related metabolic diseases. Garcinia mangostana, also known as mangosteen, is a traditional medicine ingredient used in the treatment of inflammation in Southeast Asia. In this study, the ethanolic extract of G. mangostana peel inhibited human recombinant DGAT1 and DGAT2, and PL enzyme activities in vitro. The inhibitory activity of DGAT1 and DGAT2 enzymes of four representative bioactive substances in mangosteen was confirmed. In addition, G. mangostana was confirmed to suppress the serum TG levels in C57 mice by inhibiting the absorption and synthesis of TG in the gastrointestinal tract. Through this study, it was revealed that G. mangostana extract could be useful for the prevention and amelioration of TG-related metabolic diseases such as obesity and fatty liver. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF